Non-invasive prenatal test (NIPT)

The Harmony® test is a non-invasive prenatal test. Cenata GmbH was founded jointly by Labor Enders, CeGaT GmbH and Prof. Dr. Hinrichsen. The Harmony® test reliably detects the most common chromosomal disorders in unborn children.

For further information, please visit the

Maternal blood already contains not only genetic information of the mother but also genetic information of the child from an early phase of pregnancy. This so-called “cell-free fetal DNA” (cffDNA) can be investigated for the presence of chromosomal disorders in the unborn child (e.g. trisomy 21 – “Down syndrome”) using the Harmony® test. All that is needed is a blood sample from the mother.

Advantages of the Harmony® test

  • excellent detection rate of 99.5% for trisomy 21

  • very low false positive rate of 0.06% for trisomy 21

  • excellent clinical validation, e.g. the to date biggest clinical NIPT study with 18,955 patients

  • affordable price

  • short throughput time of average 3 working days

  • Feasibility under heparin treatment

© 2016 Roche Diagnostics and Cenata GmbH. All rights reserved. Cenata® and the Cenata-Logo are registered trademarks of Cenata GmbH. HARMONY is a registered trademark of Roche. All other trademarks are the property of their respective owners.